Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764

Michael R. Lassen, Matthew Scarborough, Nigel Gilchrist, Shiva S. Tripathi, Cathy Price, Angel Horcajadas, Javier DeAndres, Ganesan Baranidharan, Sashin Ahuja, Kristian S. Otte, Emily Wood, Sarah Guest, Lloyd G. Czaplewski, Duncan McHale

Open source

DOI
10.1016/j.eclinm.2026.103834
Published
2026-03
Container
eClinicalMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.103834,
  title = {Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764},
  author = {Michael R. Lassen and Matthew Scarborough and Nigel Gilchrist and Shiva S. Tripathi and Cathy Price and Angel Horcajadas and Javier DeAndres and Ganesan Baranidharan and Sashin Ahuja and Kristian S. Otte and Emily Wood and Sarah Guest and Lloyd G. Czaplewski and Duncan McHale},
  year = {2026},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.103834},
  url = {https://doi.org/10.1016/j.eclinm.2026.103834}
}

RIS

TY  - JOUR
TI  - Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764
AU  - Michael R. Lassen
AU  - Matthew Scarborough
AU  - Nigel Gilchrist
AU  - Shiva S. Tripathi
AU  - Cathy Price
AU  - Angel Horcajadas
AU  - Javier DeAndres
AU  - Ganesan Baranidharan
AU  - Sashin Ahuja
AU  - Kristian S. Otte
AU  - Emily Wood
AU  - Sarah Guest
AU  - Lloyd G. Czaplewski
AU  - Duncan McHale
PY  - 2026
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.103834
UR  - https://doi.org/10.1016/j.eclinm.2026.103834
ER  - 

APA

Lassen, M. R., Scarborough, M., Gilchrist, N., Tripathi, S. S., Price, C., Horcajadas, A., DeAndres, J., Baranidharan, G., Ahuja, S., Otte, K. S., Wood, E., Guest, S., Czaplewski, L. G., & McHale, D. (2026). Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103834

Source records